As per the records of GLOBOCAN, 19,292,789 new cancer cases were found in 2020 globally. There is a noticeable trend of breast cancer globally. Thus, the high prevalence of cancer, strategic initiatives taken by the government for its awareness and early detection of cancer are anticipated to increase the market's growth. It has also been seen that targeted therapy is a rapidly growing era of cancer research, and researchers are constantly developing many new targets. The huge initiatives by market players and several technological advancements for cancer treatment fill the gap for numerous treatments.
According to Data Bridge Market Research the Canada Cancer Treatment Market is growing with a CAGR of 11.1% in the forecast period of 2022 to 2029 and is expected to reach USD 11,108.53 million by 2029 from USD 4,906.97 million in 2021.
“Wide Adoption of Therapy Types Increase The Market Growth”
Different types of therapy such as hormone therapy, targeted therapy, chemotherapy,radiation therapy and others. Among all the other therapies, chemotherapy market is holding the largest market share in the Canada breast cancer therapeutics market. Furthermore, chemotherapy is most used when cancer in the lymph nodes and despite of tumor size or menopausal status. It is used for the treatment of breast cancer in premenopausal women and is referred for those women who get diagnosed with early-stage breast cancer for hormone receptor negative and HER2 positive cancer. Neoadjuvant chemotherapy can be widely used to decrease the tumor size, so it can be eradicated with less widespread surgery.
What restraints the growth of Canada Cancer Treatment Market?
“Complications of Cancer Treatment”
There are several complications that are associated with cancer treatment such as bleeding, constipation, diarrhea, edema, fatigue, swelling and several other complications that hamper the growth of the market. It has been witnessed that people who have surgeries in the pelvis or abdomen may not be able to have children. Furthermore, both chemotherapy and radiation therapy to the chest can lead to heart problems. There are many survivors may have a higher risk. People who suffer from lung disease and older adults may have more lung problems. The symptoms of menopause that is caused by cancer treatment may be worse than the symptoms of general menopause. This is due to the reduction in hormones happens more quickly.
Segmentation: Canada Cancer Treatment Market
The treatment market is categorized into four notable segments based on cancer type, treatment, route of administration, and end user.
- On the basis of cancer type, the cancer treatment market is segmented into breast cancer, colorectal cancer with liver metastases, lung carcinoma, prostate cancer, ovarian cancer, head-and-neck cancer, pancreatic cancer, glioblastoma, renal cell carcinoma, anaplastic thyroid carcinoma, and sarcoma.
- On the basis of treatment, the cancer treatment market is segmented into medication, targeted therapies, radiotherapy, surgery, and others.
- On the basis of route of administration, the cancer treatment market is segmented into injectable, oral, and others.
- On the basis of end user, the cancer treatment market is segmented into hospitals and specialty clinics.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/canada-cancer-treatment-market
Recent Developments in Canada Cancer Treatment Market
- In 2020, F. Hoffman-La Roche Ltd. announced that it had received U.S. FDA approval for its drug Gavreto for treating pediatric patients above 12 years and adult patients with advanced or metastatic rearranged during transfection-mutant medullary thyroid cancer that requires systemic therapy. This has aided the company in increasing its portfolio.
- In 2019, GSK plc acquired TESARO Inc., an oncology-based biopharmaceutical company that led to the expansion of GSK's pipeline and commercial capability in oncology.
The Prominent Key Players Operating in the Canada Cancer Treatment Market Include:
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- AbbVie Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of Canada Cancer Treatment Market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Canada Cancer Treatment Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
